Earnings Flash Japan

Eltes, Last Fiscal Year Ordinary Profit Revised Downward to an Unexpected 48% Decrease

INTRANCE, Last Fiscal Year Net Income Revised Downward to a Loss

TENTIAL, Fiscal Year End Changed from January to August. Ordinary Profit is 387 million yen

Kidswell Bio, The Current Fiscal Year Ordinary Profit Loss to Narrow

Integroup, Jun-Feb (Cumulative 3Q) Ordinary Profit Decreases by 26%, Dec-Feb Ordinary Profit Turns to Loss

Perseus Proteomics, The Current Fiscal Year's Undisclosed Net Income to Narrow

LeTech, Second Half Dividend Postponed

G-NEXT, The Current Fiscal Year's Net Income to Widen

Recovery International, The Current Fiscal Year Ordinary Profit Revised Upward by 0.5％

LA Holdings, First Half Dividend Set at 165 yen

MetaReal, Last Fiscal Year Ordinary Profit Revised Downward by 60%

Feedforce Group, Jun-Feb (Cumulative 3Q) Ordinary Profit Increases by 26%, Dec-Feb Ordinary Profit Increases by 90%

SBI Leasing Services, The Current Fiscal Year Ordinary Profit Revised Upward by 13%, Raises Record High Profit Forecast

Ekitan &, The Current Fiscal Year Ordinary Profit Revised Upward by 31%

BrightPath Biotherapeutics, The Current Fiscal Year Net Income Loss Widened in Downward Revision

Koukandekirukun, The Current Fiscal Year Ordinary Profit Revised Downward by 53%

gooddays holdings, Current Fiscal Year Dividend Revised Upward by 1 yen

ACSL, Returning to Profitability This Year

Goodpatch, The Current Fiscal Year Ordinary Profit Revised Upward by 2.2 times, Highest in Three Terms

Manabi-aid, The Current Fiscal Year Net Income Revised Downward to a Loss